KANOVSKY STEPHEN M 4
4 · NEOGENOMICS INC · Filed May 9, 2025
Insider Transaction Report
Form 4
KANOVSKY STEPHEN M
Director
Transactions
- Purchase
Common Stock
2025-05-07$7.78/sh+4,000$31,124→ 40,090 total
Holdings
- 3,714
Stock Option (Right to Buy)
Exercise: $40.90From: 2022-06-02Exp: 2028-06-02→ Common Stock (3,714 underlying) - 13,882
Stock Option (Right to Buy)
Exercise: $8.10From: 2023-06-10Exp: 2029-06-10→ Common Stock (13,882 underlying) - 8,353
Stock Option (Right to Buy)
Exercise: $14.82From: 2024-08-10Exp: 2033-08-10→ Common Stock (8,353 underlying) - 8,672
Stock Option (Right to Buy)
Exercise: $13.71From: 2025-06-01Exp: 2034-06-01→ Common Stock (8,672 underlying) - 12,254
Restricted Stock Unit
Exercise: $0.00From: 2025-06-01→ Common Stock (12,254 underlying) - 4,269
Stock Option (Right to Buy)
Exercise: $22.52From: 2020-06-06Exp: 2026-06-06→ Common Stock (4,269 underlying) - 3,448
Stock Option (Right to Buy)
Exercise: $28.54From: 2021-05-28Exp: 2027-05-28→ Common Stock (3,448 underlying)
Footnotes (1)
- [F1]Once vested, the shares of common stock are not subject to expiration.